Literature DB >> 15533891

Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction.

Florencia Rosignoli1, Valeria Roca, Roberto Meiss, Nicolás Pregi, Claudia Pérez Leirós.   

Abstract

Nitric oxide is an intracellular and diffusible messenger of neurotransmitters involved in salivary secretion, as well as an inflammatory mediator in salivary gland diseases. It is synthesized by three different isoforms of nitric oxide synthase (NOS), each subject to a fine transcriptional, post-transcriptional and/or post-translational regulation. Our purpose was to study the possible mechanisms leading to NOS downregulation in submandibular glands of normal mice and in the nonobese diabetic (NOD) mouse model of salivary dysfunction with lower NOS activity. NOS activity and cGMP accumulation were determined by radioassays in submandibular glands of both mice in the presence of the protein kinase inhibitors KN-93 and bisindolylmaleimide. NOS I mRNA and protein expression and localization were assessed by RT-PCR, Western blot and immunohistochemistry. A downregulatory effect of calcium-calmodulin kinase II (CaMK II) on NOS activity in submandibular glands of both NOD and BALB/c mice was observed. Our results are consistent with a physiological regulation of NOS activity by this kinase but not by PKC in normal BALB/c mice. They are also supportive of a role for CaMK II in the lack of detectable NOS activity in submandibular glands of NOD mice. KN-93 also restored cGMP accumulation in NOD submandibular glands. The downregulation of NOS in NOD mice seems to be mainly mediated by this kinase rather than the result of a lower expression or different cellular localization of the enzyme. It was not related to different substrate or cofactors availability either.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533891      PMCID: PMC1575950          DOI: 10.1038/sj.bjp.0705952

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

Review 1.  Approaches to the treatment of Sjögren's syndrome.

Authors:  R I Fox; P Michelson
Journal:  J Rheumatol Suppl       Date:  2000-12

2.  Nitric oxide and cGMP activate Ca2+-release processes in rat parotid acinar cells.

Authors:  D K Looms; K Tritsaris; B Nauntofte; S Dissing
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

3.  Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands.

Authors:  C P Leirós; F Rosignoli; A M Genaro; M E Sales; L Sterin-Borda
Journal:  J Auton Nerv Syst       Date:  2000-03-15

Review 4.  Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.

Authors:  Saskia C A van Blokland; Marjan A Versnel
Journal:  Clin Immunol       Date:  2002-05       Impact factor: 3.969

5.  Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.

Authors:  S Yamachika; J M Nanni; K H Nguyen; L Garces; J M Lowry; C P Robinson; J Brayer; G E Oxford; A da Silveira; M Kerr; A B Peck; M G Humphreys-Beher
Journal:  J Rheumatol       Date:  1998-12       Impact factor: 4.666

Review 6.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Regulation of neuronal nitric-oxide synthase by calmodulin kinases.

Authors:  Y Hayashi; M Nishio; Y Naito; H Yokokura; Y Nimura; H Hidaka; Y Watanabe
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice.

Authors:  F Rosignoli; N B Goren; C Pérez Leirós
Journal:  Clin Immunol       Date:  2001-10       Impact factor: 3.969

9.  Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland.

Authors:  Florencia Rosignoli; Claudia Pérez Leirós
Journal:  Eur J Pharmacol       Date:  2002-03-29       Impact factor: 4.432

10.  Phosphorylation of neuronal nitric oxide synthase at Ser847 by CaM-KII in the hippocampus of rat brain after transient forebrain ischemia.

Authors:  Koji Osuka; Yasuo Watanabe; Nobuteru Usuda; Ayami Nakazawa; Kohji Fukunaga; Eishichi Miyamoto; Masakazu Takayasu; Masaaki Tokuda; Jun Yoshida
Journal:  J Cereb Blood Flow Metab       Date:  2002-09       Impact factor: 6.200

View more
  4 in total

1.  Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis.

Authors:  F Rosignoli; V Roca; R Meiss; J Leceta; R P Gomariz; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

3.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

4.  Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.

Authors:  Mario Calafat; Luciana Larocca; Valeria Roca; Vanesa Hauk; Nicolás Pregi; Alcira Nesse; Claudia Pérez Leirós
Journal:  Arthritis Res Ther       Date:  2009-04-08       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.